Free Fatty Acid Quantification Kit

Antigen: Free Fatty Acid (FFA)

Applikation: Biochemisches Assay (BCA)

Produktnummer: ABIN411658

Produktbeschreibung

Weitere Bezeichnung: Free Fatty Acid

Beschreibung: Fatty Acids play very important roles in normal metabolism and many disease development. They are precursors to a number of bioactive classes of compounds such as prostaglandins, leucotrienes and others, and have been implicated in diverse functions such as autism, immune system and inflammation response. BioVision’s Free Fatty Acid Quantification Kit provides a convenient, sensitive enzyme-based method for detecting the long-chain free fatty acids in various biological samples, such as serum, plasma and other body fluids, food, growth media, etc. In the assay, Fatty Acids are converted to their CoA derivatives, which are subsequently oxidized with the concomitant generation of color or fluorescence. C-8 (octanoate) and longer fatty acids can then be easily quantified by either colorimetric (spectrophotometry at λ = 570 nm) or fluorometric (at Ex/Em = 535/587 nm) methods with detection limit 2 μM free fatty acid in variety samples.

Anwendungen

Protokoll: The following protocol describes assays in 100 μl per microplate well. 1. Standard Curve Preparation: For the colorimetric assay, add 0, 2, 4, 6, 8, 10 μl Palmitic Acid Standard into 96-well plate individually. Adjust volume to 50 μl/well with Assay Buffer to generate 0, 2, 4, 6, 8, 10 nmol/well of the Fatty Acid Standard. For the fluorometric assay, dilute the Palmitic Acid Standard to 0.1 nmol/ μl by adding 10 μl of the Standard to 90 μl of Assay Buffer, mix well. Add 0, 2, 4, 6, 8, 10 μl into each well individually. Adjust volume to 50 μl/well with Assay Buffer to generate 0, 0.2, 0.4, 0.6, 0.8, 1.0 nmol/well of the Fatty Acid Standard. 2. Sample Preparation: For testing liquid samples, different volume of samples can be directly added to each well in a 96-well plate, then bring up the volume to 50 μl/well with Assay Buffer. For unknown samples, we suggest using different doses to ensure the readings are within the standard curve range. For testing cell or tissue samples, 10 6 cells or 10 mg tissue samples can be extracted by homogenization with 200 μl of chloroform-Triton X-100 (1% Triton X-100 in pure chloroform) in a microhomogenizer. Then spin the extract 5-10 minutes at top speed in a microcentrifuge. Collect organic phase (lower phase), air dry at 50 o C to remove chloroform. Vacuum dry 30 min to remove trace chloroform. Dissolve the dried lipids (in Triton X-100) in 200 μl of Fatty Acid Assay Buffer by vortexing extensively for 5 mins (

Applikationshinweise: Note: The solution may be slightly turbid or opalescent, but this does not affect the assay). The extraction procedure can be proportionally scaled up if larger amount of sample is desired. Use 1- 50 μl of the extracted sample per assay. 3. Acyl-CoA Synthesis: Add 2 μl ACS Reagent into all the standard and sample wells. Mix well, incubate the reaction at 37°C for 30 min. 4. Reaction Mix Preparation: Mix enough reagents for the number of assays and standard performed: For each well, prepare a total 50 μl Reaction Mix containing: 44 μl Assay Buffer 2 μl Fatty Acid Probe 2 μl Enzyme Mix 2 μl Enhancer 5. Mix well. Add 50 μl of the Reaction Mix to each well containing the Standard or test samples. Incubate the reaction for 30 min at 37 o C, protect from light. 6. Measure O.D. 570 nm for colorimetric assay or fluorescence at Ex/Em = 535/590 nm in a micro-plate reader. 7. Calculation: Subtract background value (the 0 Control) from all standard and sample readings. Plot standard curve nmol/well vs. OD570nm or fluorescence readings. Then apply the sample readings to the standard curve to obtain Fatty Acid amount in the sample wells. Fatty Acid Concentration = Fa/Sv (nmol/ μl or mM) Fa is the Fatty Acid amount (nmol) in the well obtained from standard curve. Sv is the sample volume ( μl) added to the sample well.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Publikationen

Publikationen: Murakami, Bessho, Mushiake et al.: "Major role of apolipoprotein B in cycloheximide-induced acute hepatic steatosis in mice." in: Hepatology research : the official journal of the Japan Society of Hepatology, Vol. 41, Issue 5, pp. 446-54, 2011 (PubMed).

Moya, Benet, Guzmán et al.: "Foxa1 reduces lipid accumulation in human hepatocytes and is down-regulated in nonalcoholic Fatty liver." in: PLoS ONE, Vol. 7, Issue 1, pp. e30014, 2012 (PubMed).